Enjoy complimentary customisation on priority with our Enterprise License!
The Global RNAi drug delivery market size is forecast to increase by USD 193.2 billion at a CAGR of 27.16% between 2023 and 2028. The market is experiencing significant growth due to the high target affinity and specificity of RNAi therapeutics, making them an attractive alternative to traditional small-molecule drugs. This specificity leads to minimal off-target effects and increased efficacy. The market is witnessing R&D activities from key players, driving the growth of the market. However, the high price of RNAi therapeutics remains a significant challenge, limiting their widespread adoption. Despite this, the potential benefits of RNAi therapeutics in treating various diseases, including genetic disorders and cancer, are driving the market forward. The market is expected to grow at a steady pace, with innovations in delivery technologies and manufacturing processes helping to reduce costs and improve accessibility.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Technology
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.